AU2018904658A0 - Formulation and method of use - Google Patents

Formulation and method of use

Info

Publication number
AU2018904658A0
AU2018904658A0 AU2018904658A AU2018904658A AU2018904658A0 AU 2018904658 A0 AU2018904658 A0 AU 2018904658A0 AU 2018904658 A AU2018904658 A AU 2018904658A AU 2018904658 A AU2018904658 A AU 2018904658A AU 2018904658 A0 AU2018904658 A0 AU 2018904658A0
Authority
AU
Australia
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904658A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATP INSTITUTE Pty Ltd
Original Assignee
ATP INSTITUTE Pty Ltd
Filing date
Publication date
Application filed by ATP INSTITUTE Pty Ltd filed Critical ATP INSTITUTE Pty Ltd
Publication of AU2018904658A0 publication Critical patent/AU2018904658A0/en
Priority to AU2019101234A priority Critical patent/AU2019101234B4/en
Priority to PCT/AU2019/051349 priority patent/WO2020113289A1/en
Abandoned legal-status Critical Current

Links

AU2018904658A 2018-12-07 2018-12-07 Formulation and method of use Abandoned AU2018904658A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2019101234A AU2019101234B4 (en) 2018-12-07 2019-10-09 Formulation and method of use
PCT/AU2019/051349 WO2020113289A1 (en) 2018-12-07 2019-12-09 Formulations comprising non-animal derived hydroxyproline and their use

Publications (1)

Publication Number Publication Date
AU2018904658A0 true AU2018904658A0 (en) 2018-12-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP3732137A4 (en) Microbial-based composition and method of use
EP3704239A4 (en) Casz compositions and methods of use
EP3758575A4 (en) Endoscope and method of use
EP3700527A4 (en) Papd5 inhibitors and methods of use thereof
EP3749343A4 (en) Formulation and method of use
EP3694390A4 (en) Endoscope and method of use
EP3704254A4 (en) Cas12c compositions and methods of use
EP3576782A4 (en) Construct-peptide compositions and methods of use thereof
EP3589319A4 (en) Glycan-interacting compounds and methods of use
EP3813633A4 (en) Endoscope and method of use
EP3810617A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3829413A4 (en) Endoscope and method of use
EP3860477A4 (en) Endoscope and method of use
EP3416665A4 (en) Formulation and method of use
EP3886853A4 (en) Diarylhydantoin compounds and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3710430A4 (en) Acss2 inhibitors and methods of use thereof
EP3600372A4 (en) Synthekine compositions and methods of use
EP3846808A4 (en) Papd5 inhibitors and methods of use thereof
SG11202009315WA (en) Formulation and method of preparation
EP3749691A4 (en) Angptl8-binding agents and methods of use thereof
EP3969460A4 (en) Ascaroside derivatives and methods of use
EP3765485A4 (en) Immuno-exosomes and methods of use thereof
EP3761989A4 (en) Imidazodiazepinediones and methods of use thereof
EP3572399A4 (en) Crystal form of gft-505 and preparation method and use thereof